ERBB2 and metastatic malignant neoplasm in the lymph nodes: Evidence has revealed that high expression of PD-L1 is correlated with advanced histology and lymph node metastasis in TNBC and HER2+ subtypes, indicating a poor prognosis biomarker [39].